Article thumbnail
Location of Repository

A Signature Inferred from Drosophila Mitotic Genes Predicts Survival of Breast Cancer Patients

By Christian Damasco, Antonio Lembo, Maria Patrizia Somma, Maurizio Gatti, Ferdinando Di Cunto and Paolo Provero
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.
  2. (2002). A geneexpression signature as a predictor of survival in breast cancer.
  3. (2006). A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.
  4. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
  5. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.
  6. (2006). Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.
  7. (2006). Animal cytokinesis: from parts list to mechanisms.
  8. (2008). ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
  9. (2004). Bioconductor: open software development for computational biology and bioinformatics.
  10. (2006). Common markers of proliferation.
  11. (2007). Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting.
  12. (2010). Database resources of the National Center for Biotechnology Information.
  13. (2007). Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.
  14. (2006). Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
  15. (2004). Gene expression profiling of gliomas strongly predicts survival.
  16. (2002). Gene expression profiling predicts clinical outcome of breast cancer.
  17. (2006). Gene expression profiling predicts survival in conventional renal cell carcinoma.
  18. (2005). Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.
  19. (2006). Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.
  20. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.
  21. (2008). Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
  22. (2005). Geneexpression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
  23. (2007). Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma.
  24. (2008). Identification of Drosophila mitotic genes by combining co-expression analysis and RNA interference.
  25. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors.
  26. (2007). Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling.
  27. (2008). Metaanalysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
  28. (2007). Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
  29. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
  30. (2009). Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
  31. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
  32. (2004). Prognostic value of proliferation in invasive breast cancer: a review.
  33. (2008). Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers.
  34. (2009). Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.
  35. (2007). Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
  36. (1992). Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project.
  37. (2008). Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.
  38. (2005). Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.
  39. (2005). Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis.
  40. (2007). Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.
  41. (2009). Substantially reduced expression of PIAS1 is associated with colon cancer development.
  42. (2009). Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a smallmolecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.
  43. (2009). The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer. Adv Enzyme Regul.
  44. (2007). The prognostic role of a gene signature from tumorigenic breast-cancer cells.
  45. (2008). Threegene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
  46. (2009). Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.